PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1180165
PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1180165
According to SPER Market Research, the Global Single Use Consumable Market is estimated to reach USD 10.40 billion by 2032 with a CAGR of 16.81%.
The market for consumables is expanding, and single-use technology utilization is increasing in the biopharmaceutical industry. The market is also anticipated to develop as a result of expanding use of single-use bioprocessing and biopharmaceuticals in vaccine production. One of the main drivers of the growth of the single-use consumables market is the increase in the use of single use bioprocessing in production by pharmaceutical companies. More consumers have adopted single-use consumables as a result of the emergence of products that are both affordable and user-friendly. In the approaching years, this is also anticipated to fuel market expansion. Because of single-use technologies, biopharmaceutical companies are more productive. Complex processes like product cleaning and sterilization have historically been needed to prevent cross-contamination, increasing costs for manufacturers.
COVID-19 was mainly unknown prior to the outbreak in Wuhan (China). Since then, it has evolved from a regional problem to a global epidemic. Following the World Health Organization's (WHO) declaration that the virus outbreak was a pandemic, a number of established pharmaceutical companies and young startups rushed to develop drugs and vaccines to treat the infection caused by the novel coronavirus. Numerous biopharmaceutical companies have been working hard to generate vaccines in response to the recent coronavirus outbreak. If these development initiatives pass the trial phases, single-use equipment and systems will primarily serve the clinical and commercial manufacturing platforms.